These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 36880106)

  • 1. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
    Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
    J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant period in Korea; using K-COV-N cohort in the National health insurance service.
    Lee KS; Go MJ; Choi YY; Kim MK; Seong J; Sung HK; Jeon J; Jang HC; Kim MH
    PLoS One; 2024; 19(3):e0300306. PubMed ID: 38483919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection in children evaluated in an ambulatory setting during Delta and Omicron time periods.
    Smith H; Mahon A; Moss A; Rao S
    J Med Virol; 2023 Jan; 95(1):e28318. PubMed ID: 36397139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in Severity and Clinical Manifestation of MIS-C Over SARS-CoV-2 Variant Outbreaks in Korea.
    Choe YJ; Choi EH; Choi JW; Eun BW; Eun LY; Kim YJ; Kim YH; Kim YA; Kim YK; Kwak JH; Lee H; Park JD; Jung YH; Gwack J; Lee S;
    J Korean Med Sci; 2023 Jul; 38(30):e225. PubMed ID: 37527908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2-Naïve Korean Children and Adolescents Hospitalized With COVID-19 in 2021.
    Choi YY; Choi SH; Choi JH; Kim DH; Lee JK; Eun BW; Lee H; Kim YK; Ahn B; Song SH; Yun KW
    J Korean Med Sci; 2022 Oct; 37(42):e303. PubMed ID: 36325607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
    Butt AA; Dargham SR; Loka S; Shaik RM; Chemaitelly H; Tang P; Hasan MR; Coyle PV; Yassine HM; Al-Khatib HA; Smatti MK; Kaleeckal AH; Latif AN; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    Clin Infect Dis; 2022 Aug; 75(1):e361-e367. PubMed ID: 35404391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study.
    Sankar K; Modi N; Polyak A; Directo MP; Johnson LR; Kho N; Isonaka SK; Pedraza I; Chen P; Modes ME
    BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36805880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical severity of Omicron and Delta SARS-CoV-2 infections in children.
    Ng DC; Liew CH; Tan KK; Chin L; Awang EHB; Chandirasekharan DA; Surdi Roslan MJB; Jamil MB; Zainol Abidin NZ; Cheah YK; Alias MFB; Khoo EJ
    Pediatr Int; 2024; 66(1):e15777. PubMed ID: 38863264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
    Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
    Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals.
    Leiner J; Pellissier V; Hohenstein S; König S; Schuler E; Möller R; Nachtigall I; Bonsignore M; Hindricks G; Kuhlen R; Bollmann A
    BMC Infect Dis; 2022 Oct; 22(1):802. PubMed ID: 36303111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.
    Shi HJ; Yang J; Eom JS; Ko JH; Peck KR; Kim UJ; Jung SI; Kim S; Seok H; Hyun M; Kim HA; Kim B; Joo EJ; Cheong HS; Jun CH; Wi YM; Kim J; Kym S; Lim S; Park Y
    J Korean Med Sci; 2023 Jul; 38(28):e217. PubMed ID: 37463688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diversity in the clinical features of children hospitalized with COVID-19 during the nonvariant, Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529) variant periods of SARS CoV-2: Caution for neurological symptoms in Omicron variant.
    Sahin A; Karadag-Oncel E; Buyuksen O; Ekemen-Keles Y; Ustundag G; Elvan-Tuz A; Tasar S; Didinmez-Taskirdi E; Baykan M; Kara-Aksay A; Yilmaz N; Olgac-Dundar N; Yilmaz D
    J Med Virol; 2023 Mar; 95(3):e28628. PubMed ID: 36856142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period.
    Shoji K; Akiyama T; Tsuzuki S; Matsunaga N; Asai Y; Suzuki S; Iwamoto N; Funaki T; Ohmagari N
    J Infect Chemother; 2022 Nov; 28(11):1531-1535. PubMed ID: 35963599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea.
    Lee J; Ko M; Kim S; Lim D; Park G; Lee SE
    Osong Public Health Res Perspect; 2023 Aug; 14(4):263-271. PubMed ID: 37652681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute COVID-19 in unvaccinated children without a history of previous infection during the delta and omicron periods.
    Kim JM; Han JY; Han SB
    Postgrad Med; 2023 Sep; 135(7):727-733. PubMed ID: 37585724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
    Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
    JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of characteristics and prognosis of COVID-19 patients requiring invasive mechanical ventilation during dominance of nonvariant, alpha, delta, and omicron variants in tertiary hospitals of Japan.
    Sakuramoto K; Wada D; Maruyama S; Muroya T; Saito F; Nakamori Y; Kuwagata Y
    BMC Infect Dis; 2024 Feb; 24(1):223. PubMed ID: 38374034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
    Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
    Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.